Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Lin Yan, Lin Jiaqiong, Guo Yue, Li Xiaoyong, Tan Xuexian, Long Ming, Li Yinglan, Liao Xinxue & Huang Zena. (2020) Atorvastatin protects against contrast-induced acute kidney injury via upregulation of endogenous hydrogen sulfide. Renal Failure 42:1, pages 270-281.
Read now
Read now
Articles from other publishers (26)
Liang Song, Shun Yao, Di Zheng, Yongli Xuan & Wenhua Li. (2021) Astaxanthin attenuates contrast-induced acute kidney injury in rats via ROS/NLRP3 inflammasome. International Urology and Nephrology 54:6, pages 1355-1364.
Crossref
Crossref
Michele Andreucci, Michele Provenzano, Teresa Faga, Ida Gagliardi, Antonio Pisani, Maria Perticone, Giuseppe Coppolino, Giovambattista De Sarro, Raffaele Serra & Ashour Michael. (2021) Darbepoetin alfa reduces cell death due to radiocontrast media in human renal proximal tubular cells. Toxicology Reports 8, pages 816-821.
Crossref
Crossref
Andrei Mihai Iordache, Ana Maria Buga, Dana Albulescu, Ramona Constantina Vasile, Radu Mitrut, George Georgiadis, Ioannis-Erineos Zisis, Charalampos Mamoulakis, Aristidis Tsatsakis, Anca Oana Docea & Daniela Calina. (2020) Phosphodiesterase-5 inhibitors ameliorate structural kidney damage in a rat model of contrast-induced nephropathy. Food and Chemical Toxicology 143, pages 111535.
Crossref
Crossref
Andrei Mihai Iordache, Anca Oana Docea, Ana Maria Buga, Ovidiu Zlatian, Marius Eugen Ciurea, Otilia Constantina Rogoveanu, Florin Burada, Simona Sosoi, Radu Mitrut, Charalampos Mamoulakis, Dana Albulescu, Ramona Constantina Vasile, Aristides Tsatsakis & Daniela Calina. (2020) Sildenafil and tadalafil reduce the risk of contrast-induced nephropathy by modulating the oxidant/antioxidant balance in a murine model. Food and Chemical Toxicology 135, pages 111038.
Crossref
Crossref
Luyu Yao, Honglin Dong, Cynthia X Zhao, Xin Gu, Tze-W Tan, Alireza Hamidian Jahromi & Wayne W Zhang. (2015) Evaluation of urine fibrinogen level in a murine model of contrast-induced nephropathy. Vascular 24:3, pages 273-278.
Crossref
Crossref
Lilach Shema‐Didi, Batya Kristal, Sarit Eizenberg, Nabil Marzuq, Majdy Sussan, Yulie Feldman‐Idov, Pnina Ofir & Shaul Atar. (2016) Prevention of contrast‐induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: A randomized controlled trial. Nephrology 21:4, pages 295-300.
Crossref
Crossref
Mark de Caestecker, Ben D. Humphreys, Kathleen D. Liu, William H. Fissell, Jorge Cerda, Thomas D. Nolin, David Askenazi, Girish Mour, Frank E. Harrell, Nick Pullen, Mark D. Okusa & Sarah Faubel. (2015) Bridging Translation by Improving Preclinical Study Design in AKI. Journal of the American Society of Nephrology 26:12, pages 2905-2916.
Crossref
Crossref
Fiona A.I. Duthie, Paul McGeehan, Sharleen Hill, Richard Phelps, David C. Kluth, Vipin Zamvar, Jeremy Hughes & David A. Ferenbach. (2014) The Utility of the Additive EuroSCORE, RIFLE and AKIN Staging Scores in the Prediction and Diagnosis of Acute Kidney Injury after Cardiac Surgery. Nephron Clinical Practice 128:1-2, pages 29-38.
Crossref
Crossref
Michele Andreucci, Teresa Faga, Antonio Pisani, Massimo Sabbatini, Domenico Russo & Ashour Michael. (2014) Prevention of Contrast-Induced Nephropathy through a Knowledge of Its Pathogenesis and Risk Factors. The Scientific World Journal 2014, pages 1-16.
Crossref
Crossref
Cheng Tien Wu, Te I. Weng, Li Ping Chen, Chih Kang Chiang & Shing Hwa Liu. (2013) Involvement of caspase-12-dependent apoptotic pathway in ionic radiocontrast urografin-induced renal tubular cell injury. Toxicology and Applied Pharmacology 266:1, pages 167-175.
Crossref
Crossref
Mahmoud Rafieian Kopaei, Hamid Nasri, Mehdi Nematbakhsh, Azar Baradaran, Alaleh Gheissari, Hamid Rouhi, Seyed Mohammad Ahmadi Soleimani, Milad Baradaran Ghahfarokhi, Fatemeh Ghaed Amini & Mohammadreza Ardalan. (2012) Erythropoietin ameliorates genetamicin-induced renal toxicity: A biochemical and histopathological study. Journal of Nephropathology 1:2, pages 109-116.
Crossref
Crossref
Elizabeth Moore & Rinaldo Bellomo. (2011) Erythropoietin (EPO) in acute kidney injury. Annals of Intensive Care 1:1.
Crossref
Crossref
E. M. Moore, R. Bellomo & A. D. Nichol. (2011) Erythropoietin as a Novel Brain and Kidney Protective Agent. Anaesthesia and Intensive Care 39:3, pages 356-372.
Crossref
Crossref
Y. Ishii, T. Sawada, T. Murakami, Y. Sakuraoka, T. Shiraki, A. Shimizu, K. Kubota, S. Fuchinoue & S. Teraoka. (2010) Renoprotective effect of erythropoietin against ischaemia-reperfusion injury in a non-human primate model. Nephrology Dialysis Transplantation 26:4, pages 1157-1162.
Crossref
Crossref
Danilo Fliser. 2011. Regenerative Nephrology. Regenerative Nephrology
93
101
.
Samuel N. Heyman, Seymour Rosen, Mogher Khamaisi, Jean-Marc Odee & Christian Rosenberger. 2011. Studies on Renal Disorders. Studies on Renal Disorders
229
256
.
Samuel N. Heyman, Seymour Rosen, Mogher Khamaisi, Jean-Marc Idée & Christian Rosenberger. (2010) Reactive Oxygen Species and the Pathogenesis of Radiocontrast-Induced Nephropathy. Investigative Radiology 45:4, pages 188-195.
Crossref
Crossref
Mark Nunag, Maureen Brogan & Renee Garrick. (2009) Mitigating Contrast-Induced Acute Kidney Injury Associated With Cardiac Catheterization. Cardiology in Review 17:6, pages 263-269.
Crossref
Crossref
Zhi-yong ZHANG, Chun-hua ZHOU, Xia LEI & Fa-huan YUAN. (2009) Protective effect of human erythropoietin on acute renal injury caused by abdomen open injury plus artificial seawater immersion in rats. Academic Journal of Second Military Medical University 29:5, pages 527-531.
Crossref
Crossref
Ferdinand H Bahlmann & Danilo Fliser. (2009) Erythropoietin and renoprotection. Current Opinion in Nephrology & Hypertension 18:1, pages 15-20.
Crossref
Crossref
Wanja M Bernhardt & Kai-Uwe Eckardt. (2008) Physiological basis for the use of erythropoietin in critically ill patients at risk for acute kidney injury. Current Opinion in Critical Care 14:6, pages 621-626.
Crossref
Crossref
Kevin A Sterling, Tara Tehrani & Michael R Rudnick. (2008) Clinical significance and preventive strategies for contrast-induced nephropathy. Current Opinion in Nephrology and Hypertension 17:6, pages 616-623.
Crossref
Crossref
Yukiyo Yokomaku, Toshiro Sugimoto, Shinji Kume, Shin-ichi Araki, Keiji Isshiki, Masami Chin-Kanasaki, Masayoshi Sakaguchi, Norihisa Nitta, Masakazu Haneda, Daisuke Koya, Takashi Uzu & Atsunori Kashiwagi. (2008) Asialoerythropoietin Prevents Contrast-Induced Nephropathy. Journal of the American Society of Nephrology 19:2, pages 321-328.
Crossref
Crossref
F.H. Bahlmann, J.T. Kielstein, H. Haller & D. Fliser. (2007) Erythropoietin and progression of CKD. Kidney International 72, pages S21-S25.
Crossref
Crossref
Christina Warnecke, Wanja Bernhardt, Carsten Willam, Michael S. Wiesener & Kai-Uwe Eckardt. (2007) Novel strategies for nephroprotection using hypoxia-inducible gene expression. Drug Discovery Today: Therapeutic Strategies 4:1, pages 71-77.
Crossref
Crossref
Christian Rosenberger, Seymour Rosen & Samuel N Heyman. (2006) RENAL PARENCHYMAL OXYGENATION AND HYPOXIA ADAPTATION IN ACUTE KIDNEY INJURY. Clinical and Experimental Pharmacology and Physiology 33:10, pages 980-988.
Crossref
Crossref